Physician profile
Bryan Bruner
NPI 1043439920
$7,745.79
in general payments reported to CMS, 2019-2025
52 companies · $2,216 in 2025
The $2,216 reported for 2025 was more than what 82% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,201 · 2020: $309 · 2021: $423 · 2022: $975 · 2023: $1,151 · 2024: $1,470 · 2025: $2,216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,769 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,769.01 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $727.12 | 2023-2025 | Orgovyx, Gemtesa |
| Dendreon Pharmaceuticals LLC | $610.57 | 2019-2025 | Provenge |
| Janssen Biotech, INC. | $596.48 | 2019-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $534.10 | 2019-2025 | Xtandi, Myrbetriq |
| Pfizer INC. | $518.57 | 2019-2025 | |
| Boston Scientific Corporation | $420.22 | 2019-2025 | Spaceoar Vue System - 10ml, Rezum Generator, Moses 550 D\F\L |
| Axonics, INC. | $325.67 | 2020-2024 | Axonics, Bulkamid |
| Endo Pharmaceuticals INC. | $310.84 | 2019-2024 | Xiaflex, Aveed |
| Merck Sharp & Dohme LLC | $294.66 | 2020-2025 | Lynparza, Keytruda, Bridion |
| Antares Pharma, INC. | $266.27 | 2019-2023 | Nocdurna, Tlando, Xyosted |
| Coloplast Corp | $262.10 | 2019-2023 | Speedicath |
| Abbvie INC. | $227.96 | 2019-2025 | Botox |
| Urogen Pharma, INC. | $216.02 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $197.24 | 2020-2025 | |
| Procept Biorobotics Corporation | $184.94 | 2021-2025 | Aquabeam Robotic System, Aquabeam System |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Bruner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.